VialTalk
VialTalk

Superseded. Newer COA available for this product: view newer COA.

TriVial BioWorks logo

Dual Incretin Agonist 10mg — Verification Report

From TriVial BioWorks · Lot TR10-0522 · Tested May 2026

← Back to TriVial BioWorks
VialTalk
Verification report

Dual Incretin Agonist 10mg

TriVial BioWorks

Score
89.1
Grade
B
Good
Lot TR10-0522
Tested May 2026
Report ID
94ce71a2
PurityFull credit
HPLC
99.57%
IdentityFull credit
Mass spectrometry
Confirmed
ContentPartial
Gravimetric vs label claim · tested weight not disclosed
10 mg labeled · 11.68 mg tested
EndotoxinFull credit
USP <85> compendial
Screened
Heavy metalsFull credit
ICP-MS
Screened
Batch conformityPartial
Two-batch average
Assessed
SterilityNot submitted
Not tested
Not tested
Additional screens, not scoredFentanyl screen

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →